RLAY Stock

A year in review: Relay Therapeutics Inc (RLAY)’s performance in the last year
Kenneth Phillips
While Relay Therapeutics Inc has underperformed by -3.91%, investors are advised to look at stock chart patterns for technical insight. ...

Relay Therapeutics Inc (RLAY)’s stock decline to 8.56 per share
Preston Campbell
While Relay Therapeutics Inc has underperformed by -1.04%, investors are advised to look at stock chart patterns for technical insight. ...

A year in review: Relay Therapeutics Inc (RLAY)’s performance in the last year
Arcelia Reed
While Relay Therapeutics Inc has overperformed by 3.32%, investors are advised to look at stock chart patterns for technical insight. ...

RLAY’s price-to-free cash flow ratio: How it affects investment decisions
Kenneth Phillips
Currently, Relay Therapeutics Inc’s (RLAY) stock is trading at $8.13, marking a gain of 1.25% from last night’s close. At ...





